Date: 2025/01/22 - 00:32
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but risks of developing gastrointestinal, kidney, and pancreatic issues.
Date: 2025/01/21 - 20:31
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.
Date: 2025/01/16 - 02:32
Dementia cases in the U.S. are expected to double by 2060, and poor diet is considered a risk factor. A new study found that eating processed red meat is associated with a 13% higher risk of dementia and cognitive decline.
Date: 2025/01/14 - 21:00
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively clearing up 'waste', though it remains unclear whether this could affect cognitive functions.